Effects of vitamin D supplements on bone mineral density: A systematic review and meta-Analysis

The Lancet

Volumn 383, Issue 9912, 2014, Pages 146-155

  Reid, Ian R ^a   Bolland, Mark J ^a,b   Grey, Andrew ^b  

^a UNIVERSITY OF AUCKLAND   (New Zealand)

^b AUCKLAND DISTRICT HEALTH BOARD   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

25 HYDROXYVITAMIN D; COLECALCIFEROL; ERGOCALCIFEROL; VITAMIN D;

ARTICLE; BONE DENSITY; COCHRANE LIBRARY; EMBASE; FEMUR NECK; HIP; HUMAN; META ANALYSIS; PRIORITY JOURNAL; SYSTEMATIC REVIEW; VITAMIN SUPPLEMENTATION;

EID: 84892184039     PISSN: 01406736     EISSN: 1474547X     Source Type: Journal    
DOI: 10.1016/S0140-6736(13)61647-5     Document Type: Article

References (61)

1. Arabi A, Baddoura R, El-Rassi R, Fuleihan GEH. PTH level but not 25 (OH) vitamin D level predicts bone loss rates in the elderly. Osteoporos Int 2012; 23: 971-80
2. Chapuy MC, Preziosi P, Maamer M, et al. Prevalence of vitamin D insuffi ciency in an adult normal population. Osteoporos Int 1997; 7: 439-43
3. Marwaha RK, Tandon N, Garg MK, et al. Bone health in healthy Indian population aged 50 years and above. Osteoporos Int 2011; 22: 2829-36
4. Bischoff-Ferrari HA, Kiel DP, Dawson-Hughes B, et al. Dietary calcium and serum 25-hydroxyvitamin D status in relation to BMD among US adults. J Bone Miner Res 2009; 24: 935-42
5. Committee to review dietary reference intakes for vitamin D and calcium. Dietary reference intakes for calcium and vitamin D. Washington DC: The National Academies Press, 2010
6. Dawson-Hughes B, Heaney RP, Holick MF, Lips P, Meunier PJ, Vieth R. Estimates of optimal vitamin D status. Osteoporos Int 2005; 16: 713-16
7. Avenell A, Gillespie WJ, Gillespie LD, O'Connell D. Vitamin D and vitamin D analogues for preventing fractures associated with involutional and post-menopausal osteoporosis. Cochrane Database Syst Rev 2009; 2: CD000227
8. Abrahamsen B, Masud T, Avenell A, et al. Patient level pooled analysis of 68 500 patients from seven major vitamin D fracture trials in US and Europe. BMJ 2010; 340: B5463
9. Bolland MJ, Grey A, Avenell A, Gamble GD, Reid IR. Calcium/vitamin D supplements and cardiovascular events: a re-Analysis of the Women's Health Initiative limited-Access dataset, and meta-Analysis of calcium with or without vitamin D. BMJ 2011; 342: 2040
10. Bailey RL, Dodd KW, Goldman JA, et al. Estimation of total usual calcium and vitamin D intakes in the United States. J Nutr 2010; 140: 817-22
11. Cranney A, Horsley T, O'Donnell S, et al. Eff ectiveness and safety of vitamin D in relation to bone health. Evid Rep Technol Assess (Full Rep) 2007; 158: 1-235
12. Chung M, Balk EM, Brendel M, et al. Vitamin D and calcium: a systematic review of health outcomes. Evid Rep Technol Assess (Full Rep) 2009; 183: 1-420
13. Lips P, van Schoor NM. The eff ect of vitamin D on bone and osteoporosis. Best Pract Res Clin Endocrinol Metab 2011; 25: 585-91
14. Holick MF, Binkley NC, Bischoff-Ferrari HA, et al. Evaluation, treatment, and prevention of vitamin D defi ciency: an Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab 2011; 96: 1911-30
15. Chung M, Lee J, Terasawa T, Lau J, Trikalinos TA. Vitamin D with or without calcium supplementation for prevention of cancer and fractures: an updated meta-Analysis for the US Preventive Services Task Force. Ann Intern Med 2011; 155: 827-38
16. Papadimitropoulos E, Wells G, Shea B, et al. Meta-Analysis of the effi cacy of vitamin D treatment in preventing osteoporosis in postmenopausal women. Endocrine Rev 2002; 23: 560-69
17. Higgins JPT, Altman DG. Assessing risk of bias in inlcuded studies. In: Higgins JPT, Green S, eds. Cochrane handbook for systematic reviews of interventions version 501. Chichester, UK: Wiley, 2008
18. Christiansen C, Christensen MS, McNair P, Hagen C, Stocklund KE, Transbol IB. Prevention of early postmenopausal bone loss: controlled 2-year study in 315 normal females. Eur J Clin Invest 1980; 10: 273-79
19. Dawson-Hughes B, Dallal GE, Krall EA, Harris S, Sokoll LJ, Falconer G. Eff ect of vitamin D supplementation on wintertime and overall bone loss in healthy postmenopausal women. Ann Intern Med 1991; 115: 505-12
20. Dawson-Hughes B, Harris SS, Krall EA, Dallal GE, Falconer G, Green CL. Rates of bone loss in postmenopausal women randomly assigned to one of two dosages of vitamin D. Am J Clin Nutr 1995; 61: 1140-45
21. Ooms ME, Roos JC, Bezemer PD, Vandervijgh WJF, Bouter LM, Lips P. Prevention of bone loss by vitamin D supplementation in elderly women: a randomized double-blind trial. J Clin Endocrinol Metab 1995; 80: 1052-58
22. Tuppurainen MT, Komulainen M, Kroger H, et al. Does vitamin D strengthen the increase in femoral neck bmd in osteoporotic women treated with estrogen. Osteoporos Int 1998; 8: 32-38
23. Komulainen M, Kroger H, Tuppurainen MT, et al. Prevention of femoral and lumbar bone loss with hormone replacement therapy and vitamin D, in early postmenopausal women: a population-based 5-year randomized trial. J Clin Endocrinol Metab 1999; 84: 546-52
24. Hunter D, Major P, Arden N, et al. A randomized controlled trial of vitamin D supplementation on preventing postmenopausal bone loss and modifying bone metabolism using identical twin pairs. J Bone Miner Res 2000; 15: 2276-83
25. Patel R, Collins D, Bullock S, Swaminathan R, Blake GM, Fogelman I. The eff ect of season and vitamin D supplementation on bone mineral density in healthy women: a double-masked crossover study. Osteoporos Int 2001; 12: 319-25
26. Venkatachalam S, Gupta R, Speden D, et al. A randomised controlled trial of parenteral vitamin D in coeliac disease-bone density changes. Osteoporos Int 2003; 14 (suppl 4): 39-40
27. Cooper L, Clifton-Bligh PB, Nery ML, et al. Vitamin D supplementation and bone mineral density in early postmenopausal women. Am J Clin Nutr 2003; 77: 1324-29
28. Harwood RH, Sahota O, Gaynor K, Masud T, Hosking DJ. A randomised, controlled comparison of diff erent calcium and vitamin D supplementation regimens in elderly women after hip fracture: The Nottingham Neck of Femur (NoNOF) Study. Age Ageing 2004; 33: 45-51
29. Aloia JF, Talwar SA, Pollack S, Yeh J. A randomized controlled trial of vitamin D-3 supplementation in African American women. Arch Intern Med 2005; 165: 1618-23
30. Zhu K, Devine A, Dick IM, Wilson SG, Prince RL. Eff ects of calcium and vitamin D supplementation on hip bone mineral density and calcium-related analytes in elderly ambulatory Australian women: a fi ve-year randomized controlled trial. J Clin Endocrinol Metab 2008; 93: 743-49
31. Zhu K, Bruce D, Austin N, Devine A, Ebeling PR, Prince RL. Randomized controlled trial of the eff ects of calcium with or without vitamin D on bone structure and bone-related chemistry in elderly women with vitamin D insuffi ciency. J Bone Miner Res 2008; 23: 1343-48
32. Andersen R, Molgaard C, Skovgaard LT, et al. Eff ect of vitamin D supplementation on bone and vitamin D status among Pakistani immigrants in Denmark: a randomised double-blinded placebo-controlled intervention study. Br J Nutr 2008; 100: 197-207
33. Viljakainen HT, Vaisanen M, Kemi V, et al. Wintertime vitamin D supplementation inhibits seasonal variation of calcitropic hormones and maintains bone turnover in healthy men. J Bone Miner Res 2009; 24: 346-52
34. Islam MZ, Shamim A, Viljakainen HT, et al. Eff ect of vitamin D, calcium and multiple micronutrient supplementation on vitamin D and bone status in Bangladeshi premenopausal garment factory workers with hypovitaminosis D: a double-blinded, randomised, placebo-controlled 1-year intervention. Br J Nutr 2010; 104: 241-47
35. Jorde R, Sneve M, Torjesen PA, Figenschau Y, Hansen JB, Grimnes G. No signifi cant eff ect on bone mineral density by high doses of vitamin D-3 given to overweight subjects for one year. NutrJ 2010; 9: 1
36. Verschueren SMP, Bogaerts A, Delecluse C, et al. The eff ects of whole-body vibration training and vitamin D supplementation on muscle strength, muscle mass, and bone density in institutionalized elderly women: a 6-month randomized, controlled trial. J Bone Miner Res 2011; 26: 42-49
37. Grimnes G, Joakimsen R, Figenschau Y, Torjesen PA, Almas B, Jorde R. The eff ect of high-dose vitamin D on bone mineral density and bone turnover markers in postmenopausal women with low bone mass-A randomized controlled 1-year trial. Osteoporos Int 2012; 23: 201-11
38. Rastelli AL, Taylor ME, Gao F, et al. Vitamin D and aromatase inhibitor-induced musculoskeletal symptoms (AIMSS): a phase II, double-blind, placebo-controlled, randomized trial. Breast Cancer Res Treat 2011; 129: 107-16
39. Steff ensen LH, Jorgensen L, Straume B, Mellgren SI, Kampman MT. Can vitamin D(3) supplementation prevent bone loss in persons with MS? A placebo-controlled trial. J Neurol 2011; 258: 1624-31
40. Nieves J, Cosman F, Grubert E, Ambrose B, Ralston S, Lindsay R. Skeletal eff ects of vitamin D supplementation in postmenopausal black women. Calcif Tissue Int 2012; 91: 316-24
41. Komulainen M, Kroger H, Tuppurainen MT, et al. Prevention of femoral and lumbar bone loss with hormone replacement therapy and vitamin D, in early postmenopausal women: a population-based 5-year randomized trial. J Clin Endocrinol Metab 1999; 84: 546-52
42. Masuyama R, Nakaya Y, Katsumata S, et al. Dietary calcium and phosphorus ratio regulates bone mineralization and turnover in vitamin D receptor knockout mice by aff ecting intestinal calcium and phosphorus absorption. J Bone Miner Res 2003; 18: 1217-26
43. Binkley N, Krueger DC, Morgan S, et al. Current status of clinical 25-hydroxyvitamin D measurement: An assessment of between-laboratory agreement. Clin Chim Acta 2010; 411: 1976-82
44. El-Desouki MI, Othman SM, Fouda MA. Bone mineral density and bone scintigraphy in adult Saudi female patients with osteomalacia. Saudi Med J 2004; 25: 355-58
45. Binkley N, Krueger D, Cowgill CS, et al. Assay variation confounds the diagnosis of hypovitaminosis D: A call for standardization. J Clin Endocrinol Metab 2004; 89: 3152-57
46. Bischoff-Ferrari HA, Willett WC, Wong JB, Giovannucci E, Dietrich T, Dawson-Hughes B. Fracture prevention with vitamin D supplementation: a meta-Analysis of randomized controlled trials. JAMA 2005; 293: 2257-64
47. Bischoff-Ferrari HA, Willett WC, Orav EJ, et al. A pooled analysis of vitamin D dose requirements for fracture prevention. N Engl J Med 2012; 367: 40-49
48. Reid IR, Mason B, Horne A, et al. Randomized controlled trial of calcium in healthy older women. Am J Med 2006; 119: 777-85
49. Tang BMP, Eslick GD, Nowson C, Smith C, Bensoussan A. Use of calcium or calcium in combination with vitamin D supplementation to prevent fractures and bone loss in people aged 50 years and older: a meta-Analysis. Lancet 2007; 370: 657-66
50. Chapuy MC, Arlot ME, Duboeuf F, et al. Vitamin-D3 and calcium to prevent hip fractures in elderly women. N Engl J Med 1992; 327: 1637-42
51. Murad MH, Elamin KB, Abu Elnour NO, et al. The eff ect of vitamin D on falls: a systematic review and meta-Analysis. J Clin Endocrinol Metab 2011; 96: 2997-3006
52. Francis R, Aspray T, Fraser W, et al. Vitamin D and bone health: a practical clinical guideline for patient management. April, 2013. http://www.nos.org.uk/document.doc?id=1352 (accessed May 20, 2013)
53. Lieben L, Masuyama R, Torrekens S, et al. Normocalcemia is maintained in mice under conditions of calcium malabsorption by vitamin D-induced inhibition of bone mineralization. J Clin Invest 2012; 122: 1803-15
54. Marks HD, Fleet JC, Peleg S. Transgenic expression of the human vitamin D receptor (hVDR) in the duodenum of VDR-null mice attenuates the age-dependent decline in calcium absorption. J Steroid Biochem Mol Biol 2007; 103: 513-16
55. Xue Y, Fleet JC. Intestinal vitamin D receptor is required for normal calcium and bone metabolism in mice. Gastroenterology 2009; 136: 1317-1327
56. Tanaka H, Seino Y. Direct action of 1,25-dihydroxyvitamin D on bone: VDRKO bone shows excessive bone formation in normal mineral condition. J Steroid Biochem Mol Biol 2004; 89-90: 343-45
57. Haussler MR, Haussler CA, Whitfi eld GK, et al. The nuclear vitamin D receptor controls the expression of genes encoding factors which feed the ''fountain of youth'' to mediate healthful aging. J Steroid Biochem Mol Biol 2010; 121: 88-97
58. Ott SM, Chesnut CH. Calcitriol treatment is not eff ective in postmenopausal osteoporosis. Ann Intern Med 1989; 110: 267-74
59. Sanders KM, Stuart AL, Williamson EJ, et al. Annual high-dose oral vitamin D and falls and fractures in older women: a randomized controlled trial. JAMA 2010; 303: 1815-22
60. Ebeling PR, Wark JD, Yeung S, et al. Eff ects of calcitriol or calcium on bone mineral density, bone turnover, and fractures in men with primary osteoporosis: a two-year randomized, double blind, double placebo study. J Clin Endocrinol Metab 2001; 86: 4098-103.
61. Maxmen A. The vitamin D-lemma. Nature 2011; 475: 23-25